#395 - Brain lipidology: understanding APOE, cholesterol homeostasis, Alzheimer's disease risk, and the effects of lipid-lowering therapies on brain health | Tom Dayspring, M.D.

June 7, 2026

AI Summary

5 min read

Brain cholesterol is its own universe

The brain contains about 20 to 25 grams of cholesterol—roughly 20 times more than the liver—and it holds onto that cholesterol with extraordinary tenacity. The half-life of cholesterol in the brain is about five years, compared to a few days in the periphery. This is not an accident. The brain synthesizes its own cholesterol starting in utero, and it does so almost entirely independently of the cholesterol circulating in the bloodstream. As Tom Dayspring explains, the idea that lowering plasma LDL cholesterol could "starve" the brain is a misunderstanding of two separate systems.

Two separate cholesterol economies

In the periphery, cholesterol is transported by two families of lipoproteins. The ApoB family—VLDL, IDL, and LDL—carries the bulk of cholesterol and returns it to the liver. The ApoA1 family (HDL) also participates in reverse cholesterol transport, but a key point is that LDL particles do most of the work by volume. Every cell in the body can synthesize its own cholesterol, so LDL's primary job is not delivering cholesterol to cells but bringing it back to the liver for disposal or recycling.

Continue reading the full summary in the app — free to try.

Read Full Summary →

Free • No credit card required

Listen to Audio Summary Open in App

Never miss an episode of The Peter Attia Drive

Get every new episode summarized in your inbox — free, ~5 minutes to read.

No spam. Unsubscribe anytime.

What you'll learn

1 (03:00) **Why the Brain’s Cholesterol System is Entirely Separate** - Dayspring establishes the core premise: the brain has its own independent cholesterol economy, completely divorced from the peripheral system.
2 (10:37) **The Misconception: Lowering LDL Does Not Starve the Brain** - A direct refutation of the common fear that aggressive lipid-lowering therapy robs the brain of essential cholesterol.
3 (18:26) **The Brain’s Lipoprotein: ApoE-HDL, Not ApoB-LDL** - Dayspring introduces the brain’s unique lipid transport system, which uses ApoE instead of ApoB.
4 (28:26) **ApoE Genotype: How One Amino Acid Alters Alzheimer’s Risk** - The link between the APOE gene, the ApoE protein, and dramatically different disease trajectories.
5 (30:48) **The Amyloid-Cholesterol Connection** - How dysfunctional cholesterol transport in the brain directly drives the production of toxic beta-amyloid.
6 (33:28) **The Neuron’s Safety Valve: 24S-Hydroxycholesterol** - The brain’s only mechanism to export excess cholesterol, and how it serves as a biomarker for brain health.
7 (37:04) **Do Statins Help or Hurt the Brain?** - A discussion of the only lipid-lowering drug class that crosses the blood-brain barrier.

+ Full timestamped outline available in the app

Show Notes

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Tom Dayspring is a world-renowned lipidologist and one of the most thoughtful teachers in the field of lipid metabolism. In this episode, Tom returns to The Drive for a deep dive into the relationship between lipids and brain health, beginning with the fundamentals of cholesterol transport before exploring why the brain's cholesterol system operates almost entirely independently from the rest of the body. Tom examines the roles of apoB, apoA-I, and especially apoE in cholesterol homeostasis, discusses how APOE genotype influences Alzheimer's disease risk, and unpacks the complex links between cholesterol metabolism, amyloid, and tau pathology. He also reviews what is currently known—and still uncertain—about the effects of statins, ezetimibe, omega-3 fatty acids, and emerging CETP inhibitors on brain health and neurodegenerative disease risk. Although highly technical, this conversation provides an essential framework for understanding the nuanced relationship between lipid-lowering therapies, cardiovascular disease prevention, and neurodegenerative diseases in an area often clouded by misinformation.

We discuss:

The fundamentals of cholesterol transport in the body, and how peripheral cholesterol metabolism differs from cholesterol handling in the brain [2:45];
How cholesterol is transported through plasma and stored within cells, and why lowering LDL cholesterol does not deplete the body or brain of cholesterol [11:45];
How apoB particles drive atherosclerosis, why lowering lipids matters, and the factors that influence individual cardiovascular risk [20:00];
How the brain produces and transports its own cholesterol using apoE lipoproteins independently of circulating cholesterol and apoB-containing lipoproteins [29:00];
How apoB structure influences LDL receptor binding and LDL clearance [39:00];
How neurons acquire cholesterol from apoE-containing lipoproteins and why desmosterol serves as a unique marker of cholesterol synthesis in the brain [41:45];
The difference between the APOE gene and the apoE protein, the major APOE genotypes found in humans, and how APOE4 influences Alzheimer's disease risk [48:45];
HDL function beyond cholesterol: immune function, pro